Discover company-wide updates, and other important announcements that shape our business and impact our stakeholders.
News: General
Half year 2024 results
Group performance in line with expectations reflecting more stable market conditions and operational progress
First quarter 2024 sales update
Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2024 (the three months ended 31 March 2024).
Full year results announcement 2023
27 February 2024: Croda International Plc today announce their full year results for year ending 31 December 2023.
Croda breaks ground at new Consumer Care production facility in China
27 October 2023: Croda breaks ground at new Consumer Care production facility in China
Croda’s first product launch specifically focusing on the biopesticide market
28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.
Croda introduces new bioprocessing solutions to replace banned materials
30 August 2023: Croda has introduced a range of new bioprocessing aids called Virodex™.
Half year 2023 results
Continued investment and strategic progress despite a challenging environment.
Croda announces Global Technical Centre in Hyderabad
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Croda breaks ground on new manufacturing facility for pharmaceutical excipients
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Full year 2022 results
Powerful operating model and consistent execution delivers record performance.
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Excellent first half performance driving profit growth
Excellent first half performance driving profit growth
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
Croda Pharma wins prestigious award
6 May 2022: Croda Pharma was awarded ''Best Supplier for COVID-19 Vaccine Development” at the India Biologics & Vaccines Outstanding Industry Awards (BVOIA) 2022.
Record financial performance strategy executed with agility
1 March 2022: Results for the year ended 31 December 2021.
Xampla and Croda / Incotec to work on biodegradable seed coatings
2 February 2022: Xampla and Croda/Incotec next generation, biodegradable, microplastic-free seed coatings
Transition to a dedicated Consumer Care and Life Sciences company
Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company